Figure 4 - Stock Market Returns and Announcements of COVID-19 Vaccine: An Event Study Analysis of Vaccine Companies

Cumulative abnormal return of AstraZeneca's publishment of results from phase III clinical trial.

Reference

Stock Market Returns and Announcements of COVID-19 Vaccine: An Event Study Analysis of Vaccine Companies - Scientific Figure on ResearchGate. Available from: https://www.researchgate.net/figure/Cumulative-abnormal-return-of-AstraZenecas-publishment-of-results-from-phase-III_fig4_370039085 [accessed 21 Jun 2025]

Caption

Figure 4: Cumulative abnormal return of AstraZeneca's publishment of results from phase III clinical trial.

Embed code

<a href="https://www.researchgate.net/figure/Cumulative-abnormal-return-of-AstraZenecas-publishment-of-results-from-phase-III_fig4_370039085"><img src="https://www.researchgate.net/publication/370039085/figure/fig4/AS:11431281165779484@1686074634707/Cumulative-abnormal-return-of-AstraZenecas-publishment-of-results-from-phase-III.png" alt="Cumulative abnormal return of AstraZeneca's publishment of results from phase III clinical trial."/></a>